🇺🇸 FDA
Pipeline program

JZP-258

JZP258-401

Approved small_molecule completed

Quick answer

JZP-258 for Narcolepsy is a Approved program (small_molecule) at Jazz Pharmaceuticals plc with 1 ClinicalTrials.gov record(s).

Program details

Company
Jazz Pharmaceuticals plc
Indication
Narcolepsy
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials